Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws. Freiberger JJ(1). Author information: (1)Center for Hyperbaric. The benefit of hyperbaric oxygen therapy for osteonecrosis of the femoral head is not proven. IQWiG publishes final report / Therapy should be applied only. Bisphosphonate-Related Osteonecrosis of the Jaw in Cancer Patients and Hyperbaric Oxygen Therapy, Mustafa Erkan, Oguz Bilgi, Mesut Mutluoglu, Gunalp.
|Published (Last):||8 September 2016|
|PDF File Size:||9.32 Mb|
|ePub File Size:||18.98 Mb|
|Price:||Free* [*Free Regsitration Required]|
There is currently a complete lack of relevant studies. Int J Hematol ; 84 4: The management of BRONJ remains an important clinical challenge in cancer patients and requires a multidisciplinary approach involving dentists, medical oncologists, oral and maxillofacial surgeons and others, if necessary [ 4 ]. The proposed rationale behind the beneficial effects of hyperbaric oxygen therapy in BRONJ is increased oeteonecrosis healing, reduction of edema and inflammation, stem cell mobilization and moderation of the suppression of bone turnover by bisphosphonates [ 12 ].
However, in patients who are planning to undergo oral hypdrbaric, the interruption of bisphosphonates for 3 months or longer is recommended [ 5 ].
In the advanced stage of disease, the femoral head can collapse, so that hyprebaric hip joint needs to be either surgically stabilised or replaced by a prosthesis. Systemic antibiotics, an oral antimicrobial rinse and close follow-up are recommended for patients with asymptomatic oral lesions [ 3 ].
All Published work is licensed under a Creative Commons Attribution 4. Additional relevant publications that had not already been identified by IQWiG were not reported, either. Hyperbaric oxygen therapy is a way of treatment which increases the oxygen content of osteonecrosi blood and, consequently, the amount of oxygen delivered to tissues.
J Oral Maxillofac Surg.
Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws.
There are two ongoing randomized controlled trials which are testing the effectiveness of adjunctive hyperbaric oxygen therapy in the management of BRONJ [ 12 ]. The difficulty hypergaric the treatment of patients with BRONJ is that surgical approaches such as extensive debridement of the necrotic tissue, and covering the exposed bone with soft tissue flaps often fails and leads to additional exposed bone [ 236 ].
Pamidronate Aredia and zoledronate Zometa induced avascular necrosis of the jaws: Hyperbaric oxygen therapy may hold some promise; however, its role in the management of BRONJ should be further confirmed in randomized controlled trials. Journal of the Pancreas.
Hyperbaric oxygen therapy for osteonecrosis – project plan – NIPH
The final report concludes that reliable statements on the benefit of HBOT for idiopathic osteonecrosis of the femoral head in adults are currently not possible. Comments could be submitted on this version up to 23 May Can’t read the image? As to the greater recognition of the relationship between the osteoonecrosis of bisphosphonates and oral osteonecrosis, new cases with different malignancies have been diagnosed as suffering from BRONJ.
Oral osteonecrosis associated with the use of zoledronic acid: However, hyperbari disease is relatively often associated with alcohol or nicotine abuse. The only available comparative study that investigated the research question of this report could not be included in the evaluation because of deficits in hy;erbaric and content. According to the diagnostic criteria defined by the American Association of Oral and Maxillofacial Surgeons, BRONJ is diagnosed in patients with a history of current or previous treatment with a bisphosphonate, with an exposed bone in the maxillofacial region which has continued for more than eight weeks, and with no history of radiation therapy to the jaw [ 3 ].
The cause of the idiopathic form of disease is unknown, unlike the cause of secondary or traumatic osteonecrosis of the femoral head. Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myeloma.
It remains unclear why the evidence base is so poor: Objections referring to the content of the preliminary report are discussed in the final report see pages and are fully presented in a separate document. Given the widespread use of bisphosphonates in clinical practice, even a very low incidence of oral osteonecrosis in bisphosphonate users should be considered a public emergency.
Hyperbaric oxygen therapy for osteonecrosis – project plan – project description
However, the comments submitted were considered. Hyperbaric oxygen and the cancer patient: After the paper by Marx et al. However, an increase in the reported incidence of BRONJ is expected with a wider recognition of the disease and the close follow-up of the patients using bisphosphonates.
Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: In osteonecrosis of the hip or femoral head, part of the bone of the femoral head dies off. Red blood cells, which transport oxygen, are already nearly saturated under normal conditions and can carry little more oxygen. It is currently not proven that patients with idiopathic osteonecrosis of the femoral head a specific type of destruction of the hip joint need surgery less often, or experience less pain or increased mobility of the joint if they receive hyperbaric oxygen therapy HBOT in addition to conventional treatment.
A systematic review of the literature reporting the application of hyperbaric oxygen osteonercosis and treatment of delayed radiation injuries: The final report was sent to hyperbatic contracting agency, the German Federal Joint Committee, on 8 August Hyperbaric oxygen therapy has been used in the treatment and prevention of osteoradionecrosis of the jaw for more than 30 years [ 7 ]. Therefore, patients in the control groups would by no means be arbitrarily deprived of an allegedly better treatment alternative.
In the March issue of JOP. Moreover, it is not an emergency therapy and patients are usually capable of osteonecrosks informed consent. History, etiology, prevention, and treatment.
Although this type of therapy has been tested for about 20 years, osteonecrosos only on about to patients have been published worldwide. Although early results are encouraging, evidence-based conclusions could be made after the final results of these studies are published [ 12 ].